{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:25:18Z","timestamp":1780345518999,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.vaccine.2018.08.054","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T16:20:00Z","timestamp":1535646000000},"page":"5983-5989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates"],"prefix":"10.1016","volume":"36","author":[{"given":"Ryo","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohdai","family":"Oguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Torikai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Koshizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.054_b0005","series-title":"Vaccines for the 21st century","author":"Stratton","year":"2000"},{"key":"10.1016\/j.vaccine.2018.08.054_b0010","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.054_b0015","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.08.054_b0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/01.ogx.0000452701.59180.cd","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"69","author":"Revello","year":"2014","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.vaccine.2018.08.054_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000381626","article-title":"Passive immunization against congenital cytomegalovirus infection: current state of knowledge","volume":"95","author":"J\u00fcckstock","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.vaccine.2018.08.054_b0030","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1099\/vir.0.81921-0","article-title":"Role of human cytomegalovirus UL131A in cell type-specific virus entry and release","volume":"87","author":"Adler","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0035","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1128\/JVI.78.18.10023-10033.2004","article-title":"Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes","volume":"78","author":"Hahn","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0040","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.80.2.710-722.2006","article-title":"Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion","volume":"80","author":"Ryckman","year":"2006","journal-title":"J Virol"},{"issue":"79","key":"10.1016\/j.vaccine.2018.08.054_b0045","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","article-title":"Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism","volume":"2005","author":"Wang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0050","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.08.054_b0055","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","article-title":"Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection","volume":"26","author":"Cui","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.054_b0060","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.00467-12","article-title":"Antibodies against the gH\/gL\/UL128\/UL130\/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin","volume":"86","author":"Fouts","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0065","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.vaccine.2014.03.057","article-title":"Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease","volume":"32","author":"Fu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.054_b0070","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.vaccine.2014.05.004","article-title":"Human cytomegalovirus gH\/gL\/UL128\/UL130\/UL131A complex elicits potently neutralizing antibodies in mice","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.054_b0075","doi-asserted-by":"crossref","first-page":"e1004524","DOI":"10.1371\/journal.ppat.1004524","article-title":"Human cytomegalovirus vaccine based on the envelope gH\/gL pentamer complex","volume":"10","author":"Wussow","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.08.054_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00134-08","article-title":"Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay","volume":"52","author":"Fukui","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.08.054_b0085","doi-asserted-by":"crossref","unstructured":"N. Inoue, M. Abe, R. Kobayashi, S. Yamada, Vaccine development for cytomegalovirus, In: Y. Kawaguchi, Y. Mori, H. Kimura (eds), Human Herpesviruses 2018, 271\u2013 296. https:\/\/doi.org\/10.1007\/978-981-10-7230-7_13","DOI":"10.1007\/978-981-10-7230-7_13"},{"key":"10.1016\/j.vaccine.2018.08.054_b0090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1099\/vir.0.18952-0","article-title":"Two novel spliced genes in human cytomegalovirus","volume":"84","author":"Akter","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0095","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-008-0044-7","article-title":"Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children","volume":"153","author":"Yan","year":"2008","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0100","doi-asserted-by":"crossref","first-page":"e000118","DOI":"10.1136\/bmjopen-2011-000118","article-title":"Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study","volume":"1","author":"Koyano","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2018.08.054_b0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0300-9084(96)84768-7","article-title":"WWW-Query: an on-line retrieval system for biological sequence banks","volume":"78","author":"Perri\u00e8re","year":"1996","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2018.08.054_b0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jb\/mvh070","article-title":"Preparation of recombinant \u03b1-thrombin: High-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin","volume":"135","author":"Yonemura","year":"2004","journal-title":"J Biochem"},{"key":"10.1016\/j.vaccine.2018.08.054_b0115","doi-asserted-by":"crossref","first-page":"13627","DOI":"10.1038\/ncomms13627","article-title":"Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein","volume":"7","author":"Gardner","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.08.054_b0120","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1128\/JVI.79.13.8361-8373.2005","article-title":"Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virion","volume":"79","author":"Patrone","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","article-title":"Genetic content of wild-type human cytomegalovirus","volume":"85","author":"Dolan","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/166.3.604","article-title":"Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus","volume":"166","author":"Chou","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.054_b0135","doi-asserted-by":"crossref","DOI":"10.1099\/vir.0.83685-0","article-title":"Genetic linkage among human cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from congenitally and post-natally infected Japanese infants","volume":"89","author":"Yan","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.aan1457","article-title":"Structural basis for potent antibody-mediated neutralization of human cytomegalovirus","volume":"2","author":"Chandramouli","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0145","first-page":"1","article-title":"Molmil: a molecular viewer for the PDB and beyond","author":"Bekker","year":"2016","journal-title":"J Cheminform"},{"key":"10.1016\/j.vaccine.2018.08.054_b0150","doi-asserted-by":"crossref","first-page":"e02033","DOI":"10.1128\/JVI.02033-16","article-title":"Neutralization of diverse human cytomegalovirus strains conferred by antibodies targeting viral gH\/gL\/pUL128-131 pentameric complex","volume":"91","author":"Ha","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0155","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1016\/j.vaccine.2011.09.056","article-title":"Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.054_b0160","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.00467-12","article-title":"Antibodies against the gH\/gL\/UL128\/UL130\/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin","volume":"86","author":"Fouts","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0165","doi-asserted-by":"crossref","first-page":"e0059863","DOI":"10.1371\/journal.pone.0059863","article-title":"Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection","volume":"8","author":"Lilleri","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.054_b0170","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies","volume":"111","author":"Kabanova","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.08.054_b0175","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.73.2.878-886.1999","article-title":"Strain-specific neutralization of human cytomegalovirus isolates by human sera","volume":"73","author":"Klein","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01650-16","article-title":"Impact of antibodies and strain polymorphisms on cytomegalovirus entry and spread in fibroblasts and epithelial cells","volume":"91","author":"Cui","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.054_b0185","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/v6031346","article-title":"HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex","volume":"6","author":"Zydek","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.08.054_b0190","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1128\/JVI.74.17.7720-7729.2000","article-title":"Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes","volume":"74","author":"Hobom","year":"2000","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T14:40:38Z","timestamp":1604846438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18311836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0264410X18311836"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}